Synchrony Medical's LibAirty system for addressing mucus obstruction in COPD patients gained FDA clearance in July 2025.

Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...

CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for the treatment of ...

In a longitudinal study, decrease in FEV 1 was greatest in those with mucus plugs that persisted over 5 years, followed by those who developed them during that period. Mucus plugs affect some 40% to ...

DEAR DR. GOTT: My father, age 93, suffers from chronic obstructive pulmonary disease (COPD). I have read about a device called a “lung flute.” Can this device be used to help break up mucus and clear ...

BOSTON, Jan. 7, 2026 /PRNewswire/ -- CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of a Premarket Approval (PMA) application ...

Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir ® System for the treatment of patients suffering from moderate to severe ...

Zydus Lifesciences has secured FDA approval for its generic bosentan tablets, a treatment for pulmonary arterial hypertension in children.

The company said more than 90 lakh patients in India suffer from these chronic respiratory conditions, many of whom require ...

COPD is a disease that damages your lungs over time. It may start with mild symptoms and then get worse. Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary disease ...